NCCN Quick Guide™ | Myeloproliferative Neoplasms

1 of 2 2018 NCCN QUICK GUIDE tm Myeloproliferative Neoplasms, 2018 This NCCNQUICK GUIDE tm sheet summarizes key points from the complete NCCN Guidelines for Patients ® : Myeloproliferative Neoplasms . These guidelines explain which tests and treatments are recommended by experts in cancer. To view and download the guidelines, visit NCC N.or g/patients or, to order printed copies, visit What are myeloproliferative neoplasms? They are a group of rare blood cancers called MPN, for short. They derive from blood-forming stem cells in bone marrow. There are three classic types—essential thrombocythemia, polycythemia vera, and primary myelofibrosis. 8 What tests are needed to confirm MPN and plan treatment? „„ A report of your health history and an exam of your body. 14 „„ Tests of blood cell counts and other blood values. 15 „„ Tests of your bone and bone marrow. 17 „„ Tests of markers within cells including JAK2. 18 „„ Test of your tissue type if you will have a blood stem cell transplant. 19 „„ Test of blood clotting for some people. 20 What are the options for essential thrombocythemia? „„ The goals of treatment are to prevent serious health conditions and relieve symptoms. 23 „„ To prevent blood clots, you may receive blood thinners or medicines for high blood pressure and diabetes. You may also receive help for healthy living. 24 „„ You may receive aspirin to relieve symptoms. 24 „„ You may receive medicine that lowers the number of blood cells. 26 NCCN Guidelines for Patients ® Page Number Ü NCCN GUIDELINES FOR PATIENTS ® NCCN QUICK GUIDE tm Myeloproliferative Neoplasms